Molecular, cellular and animal pharmacology of 5-aza-2'-deoxycytidine.
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000633:toxicity; D000971:Antineoplastic Combined Chemotherapy Protocols; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D004247:DNA / Q000187:drug effects / Q000378:metabolism; D000077209:Decitabine; D004351:Drug Resistance; D005786:Gene Expression Regulation / Q000187:drug effects; D007166:Immunosuppressive Agents; D007942:Leukemia, Experimental / Q000188:drug therapy; D009153:Mutagens
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009153:Mutagens; D000077209:Decitabine; D004247:DNA; D001374:Azacitidine